Literature DB >> 22482699

Structural evidence of perfluorooctane sulfonate transport by human serum albumin.

Zhipu Luo1, Xiaoli Shi, Qin Hu, Bin Zhao, Mingdong Huang.   

Abstract

Perfluorooctane sulfonate (PFOS) is a man-made fluorosurfactant and globally persistent organic pollutant. PFOS is mainly distributed in blood with a long half-life for elimination. PFOS was found mainly bound to human serum albumin (HSA) in plasma, the most abundant protein in human blood plasma, which transports a variety of endogenous and exogenous ligands. However, the structural basis of such binding remains unclear. Here, we report the crystal structure of the HSA-PFOS complex and show that PFOS binds to HSA at a molar ratio of 2:1. In addition, PFOS binding renders the HSA structure more compact. Our results provide a structural mechanism to understand the retention of surfactants in human serum.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482699     DOI: 10.1021/tx300112p

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  10 in total

1.  Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study.

Authors:  Cheryl R Stein; Mary S Wolff; Antonia M Calafat; Kayoko Kato; Stephanie M Engel
Journal:  Reprod Toxicol       Date:  2012-05-18       Impact factor: 3.143

2.  High concentrations of perfluorooctane sulfonate in mucus of tiger puffer fish Takifugu rubripes: a laboratory exposure study.

Authors:  Masato Honda; Akemi Muta; Akinari Shimazaki; Taiki Akasaka; Michiyasu Yoshikuni; Yohei Shimasaki; Yuji Oshima
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-02       Impact factor: 4.223

3.  Thyroid-stimulating hormone levels in newborns and early life exposure to endocrine-disrupting chemicals: analysis of three European mother-child cohorts.

Authors:  Marijke de Cock; Michiel R de Boer; Eva Govarts; Nina Iszatt; Lubica Palkovicova; Marja H Lamoree; Greet Schoeters; Merete Eggesbø; Tomas Trnovec; Juliette Legler; Margot van de Bor
Journal:  Pediatr Res       Date:  2017-06-07       Impact factor: 3.756

4.  Unveiling the binding mode of perfluorooctanoic acid to human serum albumin.

Authors:  Lorenzo Maso; Matteo Trande; Stefano Liberi; Giulia Moro; Elise Daems; Sara Linciano; Frank Sobott; Sonia Covaceuszach; Alberto Cassetta; Silvano Fasolato; Ligia M Moretto; Karolien De Wael; Laura Cendron; Alessandro Angelini
Journal:  Protein Sci       Date:  2021-03-05       Impact factor: 6.725

5.  Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates.

Authors:  Ulla B Mogensen; Philippe Grandjean; Carsten Heilmann; Flemming Nielsen; Pál Weihe; Esben Budtz-Jørgensen
Journal:  Environ Health       Date:  2015-06-05       Impact factor: 5.984

6.  Isolation and characterization of serum albumin from Camelus dromedarius.

Authors:  Ajamaluddin Malik; Abdulrahman Al-Senaidy; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Exp Ther Med       Date:  2013-06-06       Impact factor: 2.447

Review 7.  Interactive association of drugs binding to human serum albumin.

Authors:  Feng Yang; Yao Zhang; Hong Liang
Journal:  Int J Mol Sci       Date:  2014-02-27       Impact factor: 5.923

8.  Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study.

Authors:  Marijke de Cock; Michiel R de Boer; Marja Lamoree; Juliette Legler; Margot van de Bor
Journal:  Environ Health       Date:  2014-12-10       Impact factor: 5.984

9.  Structural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic properties.

Authors:  Bartosz Sekula; Anna Ciesielska; Przemyslaw Rytczak; Maria Koziołkiewicz; Anna Bujacz
Journal:  Biosci Rep       Date:  2016-06-03       Impact factor: 3.840

10.  Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study.

Authors:  Manhai Long; Mandana Ghisari; Lisbeth Kjeldsen; Maria Wielsøe; Bent Nørgaard-Pedersen; Erik Lykke Mortensen; Morsi W Abdallah; Eva C Bonefeld-Jørgensen
Journal:  Mol Autism       Date:  2019-01-09       Impact factor: 7.509

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.